Clinical trial

Evaluation of Stem Cell Therapy Effects on the Immune Response in Rheumatoid Arthritis Patients

NCT03333681

Study summary

ClinicalTrials.gov

Evaluation of Stem Cell Therapy Effects on the Immune Response in Rheumatoid Arthritis Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BIOLOGICAL · Unmapped registry intervention Autologous mesenchymal stem cells Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-06-20

PhasePHASE1

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

Autologous mesenchymal stem cellsBIOLOGICAL

Sponsors & collaborators

Mashhad University of Medical Scienceslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03333681 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.